In the last 12 months, insiders at InspireMD, Inc. ($NSPR) filed 149 transactions with the SEC: 30 open-market purchases totaling $1,126,309 and 10 sales totaling $99,331. Net insider sentiment: net buying.
InspireMD, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Stuka Paul (Director) — 22 transactions totaling $641,723
- ROUBIN GARY S (Director) — 23 transactions totaling $411,236
- BERMAN MICHAEL (Director) — 20 transactions totaling $369,384
- Kester Thomas J (Director) — 22 transactions totaling $259,695
- Gleason Shane Thomas (Chief Commercial Officer) — 17 transactions totaling $99,331
View all SEC Filings for InspireMD, Inc. (NSPR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Stuka Paul | Director | P | Common Stock | 2710 | $1.81 | 391,628.0000 | 73,466,501 | 0.70% | 0.00% |
| Jan. 16, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2250 | $1.61 | 1,195,212.0000 | 73,466,501 | 0.19% | 0.00% |
| Jan. 15, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2909 | $1.58 | 1,197,462.0000 | 73,466,501 | 0.24% | 0.00% |
| Jan. 22, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 8411 | $1.57 | 1,166,253.0000 | 73,466,501 | 0.72% | 0.01% |
| Jan. 27, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 4781 | $1.66 | 1,161,472.0000 | 73,466,501 | 0.41% | 0.01% |
| Jan. 28, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 12395 | $1.65 | 1,149,077.0000 | 73,466,501 | 1.07% | 0.02% |
| Jan. 29, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 5000 | $1.65 | 1,144,077.0000 | 73,466,501 | 0.44% | 0.01% |
| Jan. 30, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2900 | $1.63 | 1,141,177.0000 | 73,466,501 | 0.25% | 0.00% |
| Feb. 2, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2000 | $1.60 | 1,139,177.0000 | 73,466,501 | 0.18% | 0.00% |
| Jan. 20, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 2955 | $1.59 | 1,192,257.0000 | 73,466,501 | 0.25% | 0.00% |
| Jan. 21, 2026 | Gleason Shane Thomas | Chief Commercial Officer | S | Common Stock | 17593 | $1.62 | 1,174,664.0000 | 73,466,501 | 1.48% | 0.02% |
| Jan. 14, 2026 | Slosman Marvin | CEO and President | A | Restricted Stock Units | 1114792 | $0.00 | 3,535,658.0000 | 73,466,501 | 46.05% | 1.52% |
| Jan. 14, 2026 | BERMAN MICHAEL | Director | A | Common Stock | 88053 | $0.00 | 597,580.0000 | 73,466,501 | 17.28% | 0.12% |
| Jan. 14, 2026 | COHEN RAYMOND W | Director | A | Common Stock | 44030 | $0.00 | 92,417.0000 | 73,466,501 | 91.00% | 0.06% |
| Jan. 14, 2026 | Dearen Danny L. | Director | A | Common Stock | 44030 | $0.00 | 102,047.0000 | 73,466,501 | 75.89% | 0.06% |
| Jan. 14, 2026 | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 453390 | $0.00 | 1,200,371.0000 | 73,466,501 | 60.70% | 0.62% |
| Jan. 14, 2026 | Lawless Michael A | Chief Financial Officer | A | Common Stock | 226695 | $0.00 | 691,695.0000 | 73,466,501 | 48.75% | 0.31% |
| Jan. 14, 2026 | ROUBIN GARY S | Director | A | Common Stock | 88053 | $0.00 | 744,478.0000 | 73,466,501 | 13.41% | 0.12% |
| Jan. 14, 2026 | Stuka Paul | Director | A | Common Stock | 132076 | $0.00 | 967,899.0000 | 73,466,501 | 15.80% | 0.18% |
| Jan. 14, 2026 | Tommasoli Andrea | Chief Operating Officer | A | Common Stock | 226695 | $0.00 | 954,389.0000 | 73,466,501 | 31.15% | 0.31% |
| Jan. 14, 2026 | Ward Scott R. | Director | A | Common Stock | 88053 | $0.00 | 147,846.0000 | 73,466,501 | 147.26% | 0.12% |
| Dec. 30, 2025 | Arnold Kathryn | Director | A | Options to purchase common stock (right to buy) | 26276 | $0.00 | 111,221.0000 | 73,466,501 | 30.93% | 0.04% |
| Dec. 30, 2025 | Arnold Kathryn | Director | A | Common Stock | 55556 | $0.00 | 303,087.0000 | 73,466,501 | 22.44% | 0.08% |
| Dec. 9, 2025 | Stuka Paul | Director | P | Common Stock | 5073 | $1.81 | 835,823.0000 | 73,466,501 | 0.61% | 0.01% |
| Dec. 5, 2025 | Stuka Paul | Director | P | Common Stock | 5073 | $1.86 | 833,113.0000 | 73,466,501 | 0.61% | 0.01% |
| Dec. 4, 2025 | Stuka Paul | Director | P | Common Stock | 10130 | $1.85 | 828,040.0000 | 73,466,501 | 1.24% | 0.01% |
| Nov. 12, 2025 | Stuka Paul | Director | P | Common Stock | 13431 | $1.62 | 817,910.0000 | 73,466,501 | 1.67% | 0.02% |
| Oct. 7, 2025 | ROUBIN GARY S | Director | A | Common Stock | 48000 | $0.00 | 656,425.0000 | 73,466,501 | 7.89% | 0.07% |
| Sept. 15, 2025 | Kester Thomas J | Director | A | Common Stock | 37815 | $0.00 | 458,573.0000 | 41,928,360 | 8.99% | 0.09% |
| Sept. 15, 2025 | Kester Thomas J | Director | A | Options to purchase common stock (right to buy) | 19041 | $0.00 | 19,041.0000 | 41,928,360 | 9999.99% | 0.05% |
| July 30, 2025 | Slosman Marvin | CEO and President | P | Common Stock | 10330 | $2.42 | 2,420,866.0000 | 41,928,360 | 0.43% | 0.02% |
| July 30, 2025 | Kester Thomas J | Director | P | Common Stock | 30991 | $2.42 | 420,758.0000 | 41,928,360 | 7.95% | 0.07% |
| July 30, 2025 | Stuka Paul | Director | P | Common Stock | 20661 | $2.42 | 804,479.0000 | 41,928,360 | 2.64% | 0.05% |
| July 30, 2025 | ROUBIN GARY S | Director | P | Common Stock | 41322 | $2.42 | 608,425.0000 | 41,928,360 | 7.29% | 0.10% |
| June 29, 2025 | BERMAN MICHAEL | Director | X | Series I Warrant (right to buy) | 61248 | $0.00 | 0.0000 | 41,928,360 | 100.00% | 0.15% |
| June 25, 2025 | ROUBIN GARY S | Director | X | Common Stock | 30624 | $1.38 | 567,103.0000 | 41,928,360 | 5.71% | 0.07% |
| June 29, 2025 | BERMAN MICHAEL | Director | X | Common Stock | 61248 | $1.38 | 509,527.0000 | 41,928,360 | 13.66% | 0.15% |
| June 25, 2025 | ROUBIN GARY S | Director | X | Series I Warrant (right to buy) | 30624 | $0.00 | 0.0000 | 41,928,360 | 100.00% | 0.07% |
| July 11, 2025 | Kester Thomas J | Director | X | Common Stock | 30624 | $1.38 | 389,767.0000 | 41,928,360 | 8.53% | 0.07% |
| July 11, 2025 | Kester Thomas J | Director | X | Series I Warrant (right to buy) | 30624 | $0.00 | 0.0000 | 41,928,360 | 100.00% | 0.07% |
| July 1, 2025 | Stuka Paul | Director | X | Common Stock | 87500 | $1.38 | 783,818.0000 | 41,928,360 | 12.57% | 0.21% |
| July 1, 2025 | Stuka Paul | Director | X | Series I Warrant (right to buy) | 87500 | $0.00 | 0.0000 | 41,928,360 | 100.00% | 0.21% |
| Jan. 7, 2025 | ROUBIN GARY S | Director | A | Common Stock | 32491 | $0.00 | 534,279.0000 | 41,928,360 | 6.48% | 0.08% |
| Jan. 7, 2025 | Tommasoli Andrea | Chief Operating Officer | A | Common Stock | 232616 | $0.00 | 727,694.0000 | 41,928,360 | 46.99% | 0.55% |
| Jan. 7, 2025 | Tommasoli Andrea | Chief Operating Officer | A | Options to purchase common stock (right to buy) | 106218 | $0.00 | 282,917.0000 | 41,928,360 | 60.11% | 0.25% |
| Jan. 7, 2025 | Kester Thomas J | Director | A | Common Stock | 32491 | $0.00 | 359,143.0000 | 41,928,360 | 9.95% | 0.08% |
| Jan. 7, 2025 | Kester Thomas J | Director | A | Options to purchase common stock (right to buy) | 14836 | $0.00 | 84,947.0000 | 41,928,360 | 21.16% | 0.04% |
| Jan. 7, 2025 | Ward Scott R. | Director | A | Common Stock | 16245 | $0.00 | 59,793.0000 | 41,928,360 | 37.30% | 0.04% |
| Jan. 7, 2025 | Ward Scott R. | Director | A | Options to purchase common stock (right to buy) | 7418 | $0.00 | 24,065.0000 | 41,928,360 | 44.56% | 0.02% |
| Jan. 7, 2025 | ROUBIN GARY S | Director | A | Options to purchase common stock (right to buy) | 14836 | $0.00 | 91,743.0000 | 41,928,360 | 19.29% | 0.04% |
| Jan. 7, 2025 | Slosman Marvin | CEO and President | A | Restricted Stock Units | 558417 | $0.00 | 2,410,536.0000 | 41,928,360 | 30.15% | 1.33% |
| Jan. 7, 2025 | Slosman Marvin | CEO and President | A | Options to purchase common stock (right to buy) | 254985 | $0.00 | 937,796.0000 | 41,928,360 | 37.34% | 0.61% |
| Jan. 7, 2025 | Arnold Kathryn | Director | A | Common Stock | 32491 | $0.00 | 247,531.0000 | 41,928,360 | 15.11% | 0.08% |
| Jan. 7, 2025 | Arnold Kathryn | Director | A | Options to purchase common stock (right to buy) | 14836 | $0.00 | 84,945.0000 | 41,928,360 | 21.16% | 0.04% |
| Jan. 7, 2025 | Verta Patrick | EVP Clinical/Medical Affairs | A | Common Stock | 83072 | $0.00 | 311,532.0000 | 41,928,360 | 36.36% | 0.20% |
| Jan. 7, 2025 | Verta Patrick | EVP Clinical/Medical Affairs | A | Options to purchase common stock (right to buy) | 37933 | $0.00 | 117,281.0000 | 41,928,360 | 47.81% | 0.09% |
| Jan. 7, 2025 | Stuka Paul | Director | A | Common Stock | 48736 | $0.00 | 696,318.0000 | 41,928,360 | 7.53% | 0.12% |
| Jan. 7, 2025 | Stuka Paul | Director | A | Options to purchase common stock (right to buy) | 22254 | $0.00 | 128,129.0000 | 41,928,360 | 21.02% | 0.05% |
| Jan. 7, 2025 | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 232616 | $0.00 | 746,981.0000 | 41,928,360 | 45.22% | 0.55% |
| Jan. 7, 2025 | Gleason Shane Thomas | Chief Commercial Officer | A | Options to purchase common stock (right to buy) | 106218 | $0.00 | 289,346.0000 | 41,928,360 | 58.00% | 0.25% |
| Jan. 7, 2025 | BERMAN MICHAEL | Director | A | Common Stock | 32491 | $0.00 | 448,279.0000 | 41,928,360 | 7.81% | 0.08% |
| Jan. 7, 2025 | BERMAN MICHAEL | Director | A | Options to purchase common stock (right to buy) | 14836 | $0.00 | 84,950.0000 | 41,928,360 | 21.16% | 0.04% |
| Jan. 7, 2025 | Shore Craig | CFO and CAO | A | Common Stock | 232616 | $0.00 | 1,112,460.0000 | 41,928,360 | 26.44% | 0.55% |
| Jan. 7, 2025 | Shore Craig | CFO and CAO | A | Options to purchase common stock (right to buy) | 106218 | $0.00 | 417,706.0000 | 41,928,360 | 34.10% | 0.25% |
| June 24, 2024 | BERMAN MICHAEL | Director | X | Series H Warrant (right to buy) | 61249 | $0.00 | 0.0000 | 24,268,181 | 100.00% | 0.25% |
| June 24, 2024 | BERMAN MICHAEL | Director | X | Common Stock | 61249 | $1.38 | 415,788.0000 | 24,268,181 | 17.28% | 0.25% |
| May 28, 2024 | Kester Thomas J | Director | X | Common Stock | 30625 | $1.38 | 326,652.0000 | 24,268,181 | 10.35% | 0.13% |
| May 28, 2024 | Kester Thomas J | Director | X | Series H Warrant (right to buy) | 30625 | $0.00 | 0.0000 | 24,268,181 | 100.00% | 0.13% |
| June 5, 2024 | Stuka Paul | Director | X | Series H Warrant (right to buy) | 87500 | $0.00 | 0.0000 | 24,268,181 | 100.00% | 0.36% |
| June 5, 2024 | Stuka Paul | Director | X | Common Stock | 87500 | $1.38 | 647,582.0000 | 24,268,181 | 15.62% | 0.36% |
| May 28, 2024 | ROUBIN GARY S | Director | X | Series H Warrant (right to buy) | 30625 | $0.00 | 0.0000 | 24,268,181 | 100.00% | 0.13% |
| May 28, 2024 | ROUBIN GARY S | Director | X | Common Stock | 30625 | $1.38 | 501,788.0000 | 24,268,181 | 6.50% | 0.13% |
| Jan. 23, 2024 | ROUBIN GARY S | Director | A | Options to purchase common stock (right to buy) | 11098 | $0.00 | 76,907.0000 | 24,268,181 | 16.86% | 0.05% |
| Jan. 23, 2024 | Slosman Marvin | CEO and President | A | Options to purchase common stock (right to buy) | 215405 | $0.00 | 682,811.0000 | 24,268,181 | 46.09% | 0.89% |
| Jan. 23, 2024 | Stuka Paul | Director | A | Common Stock | 43548 | $0.00 | 560,082.0000 | 24,268,181 | 8.43% | 0.18% |
| Jan. 23, 2024 | Stuka Paul | Director | A | Options to purchase common stock (right to buy) | 16647 | $0.00 | 105,875.0000 | 24,268,181 | 18.66% | 0.07% |
| Jan. 23, 2024 | BERMAN MICHAEL | Director | A | Options to purchase common stock (right to buy) | 11098 | $0.00 | 70,114.0000 | 24,268,181 | 18.81% | 0.05% |
| Jan. 23, 2024 | BERMAN MICHAEL | Director | A | Common Stock | 29032 | $0.00 | 354,539.0000 | 24,268,181 | 8.92% | 0.12% |
| Jan. 23, 2024 | Arnold Kathryn | Director | A | Options to purchase common stock (right to buy) | 11098 | $0.00 | 70,109.0000 | 24,268,181 | 18.81% | 0.05% |
| Jan. 23, 2024 | Shore Craig | CFO and CAO | A | Common Stock | 238625 | $0.00 | 879,844.0000 | 24,268,181 | 37.21% | 0.98% |
| Jan. 23, 2024 | Shore Craig | CFO and CAO | A | Options to purchase common stock (right to buy) | 91218 | $0.00 | 311,488.0000 | 24,268,181 | 41.41% | 0.38% |
| Jan. 23, 2024 | ROUBIN GARY S | Director | A | Common Stock | 29032 | $0.00 | 471,163.0000 | 24,268,181 | 6.57% | 0.12% |
| Jan. 23, 2024 | Slosman Marvin | CEO and President | A | Restricted Stock Units | 563499 | $0.00 | 1,852,119.0000 | 24,268,181 | 43.73% | 2.32% |
| Jan. 23, 2024 | Kester Thomas J | Director | A | Common Stock | 29032 | $0.00 | 296,075.0000 | 24,268,181 | 10.87% | 0.12% |
| Jan. 23, 2024 | Kester Thomas J | Director | A | Options to purchase common stock (right to buy) | 11098 | $0.00 | 70,111.0000 | 24,268,181 | 18.81% | 0.05% |
| Jan. 23, 2024 | Verta Patrick | EVP Clinical/Medical Affairs | A | Common Stock | 85720 | $0.00 | 228,460.0000 | 24,268,181 | 60.05% | 0.35% |
| Jan. 23, 2024 | Verta Patrick | EVP Clinical/Medical Affairs | A | Options to purchase common stock (right to buy) | 32768 | $0.00 | 79,348.0000 | 24,268,181 | 70.35% | 0.14% |
| Jan. 23, 2024 | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 238625 | $0.00 | 514,365.0000 | 24,268,181 | 86.54% | 0.98% |
| Jan. 23, 2024 | Gleason Shane Thomas | Chief Commercial Officer | A | Options to purchase common stock (right to buy) | 91218 | $0.00 | 183,128.0000 | 24,268,181 | 99.25% | 0.38% |
| Jan. 23, 2024 | Tommasoli Andrea | Chief Operating Officer | A | Common Stock | 238625 | $0.00 | 495,078.0000 | 24,268,181 | 93.05% | 0.98% |
| Jan. 23, 2024 | Tommasoli Andrea | Chief Operating Officer | A | Options to purchase common stock (right to buy) | 91218 | $0.00 | 176,699.0000 | 24,268,181 | 106.71% | 0.38% |
| Jan. 23, 2024 | Arnold Kathryn | Director | A | Common Stock | 29032 | $0.00 | 215,040.0000 | 24,268,181 | 15.61% | 0.12% |
| Jan. 2, 2024 | Kester Thomas J | Director | A | Common Stock | 3183 | $0.00 | 267,043.0000 | 24,268,181 | 1.21% | 0.01% |
| Jan. 2, 2024 | BERMAN MICHAEL | Director | A | Common Stock | 3782 | $0.00 | 325,507.0000 | 24,268,181 | 1.18% | 0.02% |
| Jan. 2, 2024 | Arnold Kathryn | Director | A | Common Stock | 1661 | $0.00 | 186,008.0000 | 24,268,181 | 0.90% | 0.01% |
| Jan. 2, 2024 | ROUBIN GARY S | Director | A | Common Stock | 3229 | $0.00 | 442,131.0000 | 24,268,181 | 0.74% | 0.01% |
| Nov. 30, 2023 | ROUBIN GARY S | Director | P | Common Stock | 50000 | $2.53 | 438,902.0000 | 0 | 12.86% | 0.00% |
| Oct. 2, 2023 | Kester Thomas J | Director | A | Common Stock | 2614 | $0.00 | 263,860.0000 | 0 | 1.00% | 0.00% |
| Oct. 2, 2023 | BERMAN MICHAEL | Director | A | Common Stock | 3106 | $0.00 | 321,725.0000 | 0 | 0.97% | 0.00% |
| Oct. 2, 2023 | Arnold Kathryn | Director | A | Common Stock | 1364 | $0.00 | 184,347.0000 | 0 | 0.75% | 0.00% |
| Oct. 2, 2023 | ROUBIN GARY S | Director | A | Common Stock | 2652 | $0.00 | 388,902.0000 | 0 | 0.69% | 0.00% |
| Aug. 28, 2023 | Gleason Shane Thomas | Chief Commercial Officer | A | Common Stock | 19290 | $0.00 | 275,740.0000 | 0 | 7.52% | 0.00% |
| Aug. 28, 2023 | Gleason Shane Thomas | Chief Commercial Officer | A | Options to purchase common stock (right to buy) | 6430 | $0.00 | 91,910.0000 | 0 | 7.52% | 0.00% |
| July 1, 2023 | Arnold Kathryn | Director | A | Common Stock | 1772 | $0.00 | 182,983.0000 | 0 | 0.98% | 0.00% |
| July 1, 2023 | ROUBIN GARY S | Director | A | Common Stock | 3445 | $0.00 | 386,250.0000 | 0 | 0.90% | 0.00% |
| July 1, 2023 | Kester Thomas J | Director | A | Common Stock | 3396 | $0.00 | 261,246.0000 | 0 | 1.32% | 0.00% |
| July 1, 2023 | BERMAN MICHAEL | Director | A | Common Stock | 4351 | $0.00 | 318,619.0000 | 0 | 1.38% | 0.00% |
| May 17, 2023 | Slosman Marvin | CEO and President | A | Restricted Stock Units | 1045150 | $0.00 | 1,288,620.0000 | 0 | 429.27% | 0.00% |
| May 17, 2023 | Arnold Kathryn | Director | A | Options to purchase common stock (right to buy) | 49750 | $0.00 | 59,011.0000 | 0 | 537.20% | 0.00% |
| May 17, 2023 | Arnold Kathryn | Director | A | Common Stock | 149260 | $0.00 | 181,211.0000 | 0 | 467.15% | 0.00% |
| May 17, 2023 | ROUBIN GARY S | Director | A | Options to purchase common stock (right to buy) | 49750 | $0.00 | 65,809.0000 | 0 | 309.80% | 0.00% |
| May 17, 2023 | ROUBIN GARY S | Director | A | Common Stock | 149260 | $0.00 | 382,805.0000 | 0 | 63.91% | 0.00% |
| May 17, 2023 | Kester Thomas J | Director | A | Options to purchase common stock (right to buy) | 49750 | $0.00 | 59,013.0000 | 0 | 537.08% | 0.00% |
| May 17, 2023 | Kester Thomas J | Director | A | Common Stock | 149260 | $0.00 | 257,850.0000 | 0 | 137.45% | 0.00% |
| May 17, 2023 | Tommasoli Andrea | Chief Operating Officer | A | Options to purchase common stock (right to buy) | 59690 | $0.00 | 85,481.0000 | 0 | 231.44% | 0.00% |
| May 17, 2023 | Tommasoli Andrea | Chief Operating Officer | A | Common Stock | 179080 | $0.00 | 256,453.0000 | 0 | 231.45% | 0.00% |
| May 17, 2023 | BERMAN MICHAEL | Director | A | Options to purchase common stock (right to buy) | 49750 | $0.00 | 59,016.0000 | 0 | 536.91% | 0.00% |
| May 17, 2023 | BERMAN MICHAEL | Director | A | Common Stock | 149260 | $0.00 | 314,584.0000 | 0 | 90.28% | 0.00% |
| May 17, 2023 | Gleason Shane Thomas | VP Global Marketing | A | Options to purchase common stock (right to buy) | 85480 | $0.00 | 85,480.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | Gleason Shane Thomas | VP Global Marketing | A | Common Stock | 256450 | $0.00 | 256,450.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | Stuka Paul | Director | A | Options to purchase common stock (right to buy) | 75220 | $0.00 | 89,228.0000 | 0 | 536.98% | 0.00% |
| May 17, 2023 | Stuka Paul | Director | A | Common Stock | 225680 | $0.00 | 516,534.0000 | 0 | 77.59% | 0.00% |
| May 17, 2023 | Shore Craig | CFO and CAO | A | Options to purchase common stock (right to buy) | 174190 | $0.00 | 220,270.0000 | 0 | 378.02% | 0.00% |
| May 17, 2023 | Shore Craig | CFO and CAO | A | Common Stock | 522580 | $0.00 | 641,219.0000 | 0 | 440.48% | 0.00% |
| May 17, 2023 | Slosman Marvin | CEO and President | A | Options to purchase common stock (right to buy) | 348380 | $0.00 | 467,406.0000 | 0 | 292.69% | 0.00% |
| May 12, 2023 | Stuka Paul | Director | P | Common Stock | 175000 | $1.63 | 290,854.0000 | 0 | 151.05% | 0.00% |
| May 12, 2023 | Stuka Paul | Director | P | Series K Warrants to purchase Common Stock | 87500 | $1.63 | 87,500.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Stuka Paul | Director | P | Series J Warrants to purchase Common Stock | 87500 | $1.63 | 87,500.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Stuka Paul | Director | P | Series I Warrants to purchase Common Stock | 87500 | $1.63 | 87,500.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Kester Thomas J | Director | P | Series J Warrants to purchase Common Stock | 30625 | $1.63 | 30,625.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Kester Thomas J | Director | P | Series I Warrants to purchase Common Stock | 30624 | $1.63 | 30,624.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Kester Thomas J | Director | P | Series H Warrants to purchase Common Stock | 30625 | $1.63 | 30,625.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Kester Thomas J | Director | P | Series K Warrants to purchase Common Stock | 30624 | $1.63 | 30,624.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | BERMAN MICHAEL | Director | P | Common Stock | 122497 | $1.63 | 165,324.0000 | 0 | 286.03% | 0.00% |
| May 12, 2023 | BERMAN MICHAEL | Director | P | Series H Warrants to purchase Common Stock | 61249 | $1.63 | 61,249.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | BERMAN MICHAEL | Director | P | Series I Warrants to purchase Common Stock | 61248 | $1.63 | 61,248.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | BERMAN MICHAEL | Director | P | Series J Warrants to purchase Common Stock | 61249 | $1.63 | 61,249.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | BERMAN MICHAEL | Director | P | Series K Warrants to purchase Common Stock | 61248 | $1.63 | 61,248.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | ROUBIN GARY S | Director | P | Common Stock | 61249 | $1.63 | 233,545.0000 | 0 | 35.55% | 0.00% |
| May 12, 2023 | ROUBIN GARY S | Director | P | Series H Warrants to purchase Common Stock | 30625 | $1.63 | 30,625.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | ROUBIN GARY S | Director | P | Series I Warrants to purchase Common Stock | 30624 | $1.63 | 30,624.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | ROUBIN GARY S | Director | P | Series J Warrants to purchase Common Stock | 30625 | $1.63 | 30,625.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | ROUBIN GARY S | Director | P | Series K Warrants to purchase Common Stock | 30624 | $1.63 | 30,624.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Stuka Paul | Director | P | Series H Warrants to purchase Common Stock | 87500 | $1.63 | 87,500.0000 | 0 | 9999.99% | 0.00% |
| May 12, 2023 | Kester Thomas J | Director | P | Common Stock | 61249 | $1.63 | 108,590.0000 | 0 | 129.38% | 0.00% |
| April 1, 2023 | Arnold Kathryn | Director | A | Common Stock | 4167 | $0.00 | 31,951.0000 | 0 | 15.00% | 0.00% |
| April 1, 2023 | ROUBIN GARY S | Director | A | Common Stock | 8102 | $0.00 | 172,296.0000 | 0 | 4.93% | 0.00% |
| April 1, 2023 | BERMAN MICHAEL | Director | A | Common Stock | 9491 | $0.00 | 42,827.0000 | 0 | 28.47% | 0.00% |
| April 1, 2023 | Kester Thomas J | Director | A | Common Stock | 7986 | $0.00 | 47,341.0000 | 0 | 20.29% | 0.00% |